Horizon 2020
The EU Framework Programme for Research and Innovation

Effective targeted treatment for hairy cell leukaemia

An EU-funded project is conducting groundbreaking research into a rare form of leukaemia, proving the effectiveness in patients of non-chemotherapy-based treatments that target the genetic cause of the disease.

The Hairy Cell Leukemia project, launched by the Institute of Hematology at the University of Perugia in Italy with funding from the European Research Council, is one of the world’s foremost initiatives to develop a targeted therapy for hairy cell leukaemia (HCL), a rare form of blood cancer.

Read more

Rare Disease Day

Dr. Tiacci, University of Perugia, © E. Tiacci

Project information

Article
#H2020